Alafair Biosciences Launches VersaWrap® Tendon Protector
Austin, TX USA, December 21, 2017 – Alafair Biosciences, Inc., an early-stage biotechnology company, today announced that it has launched its first product, VersaWrap® Tendon Protector (VersaWrap®), in the U.S. market. VersaWrap® is an ultrathin, sutureless, bioresorbable hydrogel that protects tendon gliding by creating a gelatinous layer between injured tendons and surrounding soft tissues.
"There had been a gap in our armamentarium for avoiding tendon adhesions following tendon repair procedures, particularly in confined areas of the hand, wrist, foot and ankle,” stated Cameron Atkinson, MD, an orthopedic surgeon with a specialty in hand and wrist procedures and the first surgeon to clinically implant VersaWrap. "VersaWrap fills that gap. The ultrathin profile of VersaWrap provides a novel solution to this clinical need. It wrapped beautifully between the tendons at the dorsum of the wrist, and the sutureless application made it quick and easy to position it exactly where I needed it prior to closure.”
VersaWrap® Tendon Protector is the first product in the VersaWrap® family of products to receive 510(k) clearance and is indicated for the management and protection of tendon injuries in which there has been no substantial loss of tendon tissue.
“The clinical launch of VersaWrap® is a significant milestone for Alafair. We believe that its ultrathin profile and unique handling characteristics will provide surgeons with a compelling clinical solution for tendon repair procedures and that our patented hydrogel technology has diverse applications in the medical device and regenerative medicine segments,” stated Greg Brophy, CEO of Alafair. "We are excited to enter the next phase of growth for Alafair with the commercial launch of this product."
About VersaWrap® Tendon Protector (VersaWrap®)
VersaWrap® is a bioresorbable implant (device), designed to serve as an interface between the tendon or tendon sheath and the surrounding tissues, providing a non-constricting, protective encasement for injured tendons. VersaWrap® consists of a sheet and a wetting solution. The VersaWrap® sheet is easy to handle, can be cut to size, and is designed for placement on or around injured tendons. The sheet can be repositioned as needed. Once positioned, the VersaWrap® solution is applied to the sheet surface causing conformability to underlying tissues and a gelatinous layer to facilitate tendon gliding while protecting the tendon from unwanted scar tissue attachment.
About Alafair Biosciences, Inc. (www.alafairbiosciences.com)
Alafair is an early-stage biotechnology company developing a novel suite of products based on its patented hydrogel technology. Its proprietary technology is simple, yet revolutionary, offering innovative clinical solutions to improve patient outcomes.
For more information, contact email@example.com